BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18658193)

  • 1. Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation.
    Hilton R; Tong CY
    J Antimicrob Chemother; 2008 Nov; 62(5):855-9. PubMed ID: 18658193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.
    Faguer S; Hirsch HH; Kamar N; Guilbeau-Frugier C; Ribes D; Guitard J; Esposito L; Cointault O; Modesto A; Lavit M; Mengelle C; Rostaing L
    Transpl Int; 2007 Nov; 20(11):962-9. PubMed ID: 17666021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus and BK polyomavirus infection after renal transplantation].
    De Paolis P; Gervasio E; Tedesco M; Favaro' A; Iappelli M; Di Giulio S
    G Ital Nefrol; 2009; 26 Suppl 45():S46-53. PubMed ID: 19382094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.
    Wu JK; Harris MT
    Ann Pharmacother; 2008 Nov; 42(11):1679-85. PubMed ID: 18957628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polyomavirus BK-associated nephropathy after kidney transplantation].
    Ginevri F; Azzi A; Botti G; Comoli P
    G Ital Nefrol; 2006; 23(6):575-84. PubMed ID: 17173264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: a case report.
    Cekmen MB; Bakirdoven S; Sayan M; Yilmaz A
    Transplant Proc; 2012 Dec; 44(10):3044-7. PubMed ID: 23195024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral load monitoring in BK virus-associated nephropathy.
    Vats A
    Nephrol News Issues; 2002 May; Suppl():S17-9. PubMed ID: 12108986
    [No Abstract]   [Full Text] [Related]  

  • 9. Antivirals for the treatment of polyomavirus BK replication.
    Rinaldo CH; Hirsch HH
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):105-15. PubMed ID: 17266458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.
    Duclos AJ; Krishnamurthi V; Lard M; Poggio E; Kleeman M; Winans C; Fatica R; Nurko S
    Transplant Proc; 2006 Dec; 38(10):3666-72. PubMed ID: 17175362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Pallet N; Burgard M; Quamouss O; Rabant M; Bererhi L; Martinez F; Thervet E; Anglicheau D; Noel LH; Rouzioux C; Legendre C
    Transplantation; 2010 Jun; 89(12):1542-4. PubMed ID: 20559110
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.
    Jung YH; Moon KC; Ha JW; Kim SJ; Ha IS; Cheong HI; Kang HG
    Pediatr Transplant; 2013 Mar; 17(2):E50-4. PubMed ID: 23210794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement.
    Boudreault AA; Courtemanche C; Latulippe E; Côté I; Houde I; Deschênes L
    J Clin Virol; 2009 Aug; 45(4):318-21. PubMed ID: 19559645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients.
    Trofe J; Hirsch HH; Ramos E
    Transpl Infect Dis; 2006 Jun; 8(2):76-85. PubMed ID: 16734630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
    Drachenberg CB; Hirsch HH; Papadimitriou JC; Gosert R; Wali RK; Munivenkatappa R; Nogueira J; Cangro CB; Haririan A; Mendley S; Ramos E
    Transplantation; 2007 Aug; 84(3):323-30. PubMed ID: 17700156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
    Wu SW; Chang HR; Lian JD
    Nephrol Dial Transplant; 2009 Mar; 24(3):1034-8. PubMed ID: 19059933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK virus nephropathy in renal transplant patients in London.
    White LH; Casian A; Hilton R; Macphee IA; Marsh J; Sweny P; Trevitt R; Frankel AH; Warrens AN;
    Transplantation; 2008 Apr; 85(7):1008-15. PubMed ID: 18408582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.
    Viscount HB; Eid AJ; Espy MJ; Griffin MD; Thomsen KM; Harmsen WS; Razonable RR; Smith TF
    Transplantation; 2007 Aug; 84(3):340-5. PubMed ID: 17700158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.